Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Elevance Health, Inc. Common Stock
(NY:
ELV
)
417.25
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Mar 13, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Elevance Health, Inc. Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Elevance Health and Clayton, Dubilier & Rice Sign Agreement to Launch Strategic Partnership to Advance Primary Care Delivery
April 15, 2024
From
Elevance Health, Inc.
Via
Business Wire
If You Invested $1000 In This Stock 20 Years Ago, You Would Have $11,000 Today
April 12, 2024
Via
Benzinga
Deep Dive Into Elevance Health Stock: Analyst Perspectives (7 Ratings)
April 04, 2024
Via
Benzinga
Elevance Health to Hold Conference Call and Webcast to Discuss First Quarter 2024 Results on April 18, 2024
April 03, 2024
From
Elevance Health, Inc.
Via
Business Wire
Israel Kills Top Iranian General – Oil Rises – Not Great For Stock Market's No Inflation Story
April 02, 2024
To gain an edge, this is what you need to know today. Raise Hedges It is time to raise hedges. As full disclosure, a signal was given to The Arora Report members.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
$100 Invested In This Stock 10 Years Ago Would Be Worth $500 Today
April 01, 2024
Via
Benzinga
How Is The Market Feeling About Elevance Health?
March 26, 2024
Via
Benzinga
UnitedHealth, Health Insurers Tumble On Medicare Advantage Rates
April 01, 2024
Final Medicare Advantage rates were unchanged vs. the initial proposal.
Via
Investor's Business Daily
How Much Does It Cost To Make Novo Nordisk's Ozempic? Shockingly Low Against $1,000 Price Tag, Study Shows
March 28, 2024
Study reveals stark contrast: Novo Nordisk's Ozempic diabetes drug costs nearly $1,000 monthly in the U.S., yet could be produced for less than $5. This underscores the affordability challenge faced by...
Via
Benzinga
Insurance Coverage For Weight Loss Drugs - Elevance, CVS Health Become First To Extend Coverage To Novo Nordisk's Successful Wegovy For Certain Patients
March 28, 2024
Major U.S. health insurers CVS Health, Elevance Health, and Kaiser Permanente now reimburse for Novo Nordisk's Wegovy for specific Medicare individuals with heart-related conditions. This shift aims to...
Via
Benzinga
3 Stocks To Buy For Decreased Volatility
March 23, 2024
Here are three low-beta stocks that could all be considered for those looking for a more conservative approach.
Via
Talk Markets
3 Stocks To Buy For Decreased Volatility
March 20, 2024
Beta measures a stock's volatility in comparison to a relevant benchmark. The market, such as the S&P 500 Index, has a beta of 1.0.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
$100 Invested In Elevance Health 15 Years Ago Would Be Worth This Much Today
March 13, 2024
Via
Benzinga
Analyst Scoreboard: 6 Ratings For Elevance Health
March 06, 2024
Via
Benzinga
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $5,500 Today
February 29, 2024
Via
Benzinga
Kroger Passes The Baton: Sells Specialty Pharmacy Division To CarelonRx
March 19, 2024
Kroger sells specialty pharmacy business to CarelonRx, a subsidiary of Elevance Health, for undisclosed amount. Deal expected to close in 2nd half of 2024, will not impact 2024 guidance.
Via
Benzinga
Elevance Health Announces Closing of Paragon Healthcare Acquisition
March 11, 2024
From
Elevance Health, Inc.
Via
Business Wire
Healthcare Needs Will Soar As The Population Grows Older, Presenting A Profit Opportunity
February 22, 2024
The aging of our society puts new demands on our economy. A smaller number of working-age people will be expected to support a larger group of older folks who have left the labor force.
Via
Talk Markets
Topics
Economy
Exposures
Economy
Elevance Health Announces Appearance at the Cowen 44th Annual Health Care Conference
February 22, 2024
From
Elevance Health, Inc.
Via
Business Wire
Peeling Back The Layers: Exploring Elevance Health Through Analyst Insights
February 14, 2024
Via
Benzinga
$100 Invested In This Stock 20 Years Ago Would Be Worth $1,200 Today
February 13, 2024
Via
Benzinga
Here's How Much $1000 Invested In Elevance Health 20 Years Ago Would Be Worth Today
February 01, 2024
Via
Benzinga
Elevance Health Announces Appearance at Barclays 26th Annual Global Healthcare Conference
February 22, 2024
From
Elevance Health, Inc.
Via
Business Wire
Elevance Health Named in Top 10 of America’s Most JUST Companies by JUST Capital and CNBC
February 05, 2024
From
Elevance Health, Inc.
Via
Business Wire
Navigating 4 Analyst Ratings For Elevance Health
January 25, 2024
Via
Benzinga
5 top healthcare stocks for earnings growth in 2024
January 25, 2024
2024 holds promise for healthcare stocks, with Humana, Elevance, and others expected to boost earnings, as analysts say many industry pressures have been removed.
Via
MarketBeat
Elevance Health (ELV) Q4 2023 Earnings Call Transcript
January 24, 2024
ELV earnings call for the period ending December 31, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Health Insurer Elevance's Q4 Earnings: Dividend Increase, Drop In Medicaid Enrollment, Upbeat 2024 Outlook
January 24, 2024
Elevance Health excels with Q4 2023 revenues of $42.45B, up 7% YoY, surpassing consensus. Explore the growth drivers, profit insights, and future projections.
Via
Benzinga
Elevance Health Reports Results for Fourth Quarter and Full Year 2023; Sets Full Year 2024 Outlook
January 24, 2024
From
Elevance Health, Inc.
Via
Business Wire
Earnings Scheduled For January 24, 2024
January 24, 2024
Companies Reporting Before The Bell • Freeport-McMoRan (NYSE:FCX) is estimated to report quarterly earnings at $0.22 per share on revenue of $5.86 billion.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.